[1] |
DREW D A, WEINER D E, TIGHIOUART H, et al. Cognitive function and all-cause mortality in maintenance hemodialysis patients[J]. Am J Kidney Dis, 2015, 65(2):303-311.
DOI
URL
|
[2] |
MANDIC A, CAVAR I, SKORO I, et al. Body composition and inflammation in hemodialysis patients[J]. Ther Apher Dial, 2017, 21(6):556-564.
DOI
URL
|
[3] |
CARRERO J J, STENVINKEL P. Inflammation in end-stage renal disease-what have we learned in 10 years?[J]. Semin Dial, 2010, 23(5):498-509.
DOI
URL
|
[4] |
胡美玲, 蒙如庆. 维持性血液透析患者微炎症状态的治疗进展[J]. 医学综述, 2019, 25(1):87-92.
|
[5] |
侯凡凡, 马志刚, 梅长林, 等. 中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J]. 中华医学杂志, 2005, 85(7):458-463.
|
[6] |
VILLANUEVA M P, MOLLAR A, PALAU P, et al. Procalcitonin and long-term prognosis after an admission for acute heart failure[J]. Eur J Intern Med, 2015, 26(1):42-48.
DOI
URL
|
[7] |
ASSICOT M, GENDREL D, CARSIN H, et al. High serum procalcitonin concentrations in patients with sepsis and infection[J]. Lancet, 1993, 341(8844):515-518.
DOI
URL
|
[8] |
顾峰, 吴艳芬, 王志宏, 等. 降钙素原在维持性血液透析合并慢性心力衰竭患者诊断中的价值[J]. 同济大学学报(医学版), 2020, 41(5):617-624.
|
[9] |
SARAN R, ROBINSON B, ABBOTT K C, et al. US renal data system 2018 annual data report:epidemiology of kidney disease in the United States[J]. Am J Kidney Dis, 2020, 75(1 Suppl 1):A6-A7.
DOI
URL
|
[10] |
钱香蓓, 吴智明. 血液透析患者血清镁与身体组成成分及生存率的相关性[J]. 检验医学, 2021, 36(8):823-827.
|
[11] |
TURGUTALP K, OZTURK S, ARICI M, et al. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19[J]. BMC Nephrology, 2021, 22(1):29.
DOI
URL
|
[12] |
陈力平, 冯明. NLR联合CRP与PCT对慢性肾衰竭维持性血液透析患者细菌感染的诊断价值[J]. 中华医院感染学杂志, 2021, 31(12):1861-1864.
|
[13] |
XU N, BO Q, SHAO R, et al. Chitinase-3-like-1 promotes M2 macrophage differentiation and induces choroidal neovascularization in neovascular age-related macular degeneration[J]. Invest Ophthalmol Vis Sci, 2019, 60(14):4596-4605.
DOI
URL
|
[14] |
WHANG K T, VATH S D, BECKER K L, et al. Procalcitonin and proinflammatory cytokine interactions in sepsis[J]. Shock, 2000, 14(1):73-78.
DOI
URL
|
[15] |
LIAPPIS A P, GIBBS K W, NYLEN E S, et al. Exogenous procalcitonin evokes a pro-inflammatory cytokine response[J]. Inflamm Res, 2011, 60(2):203-207.
DOI
URL
|
[16] |
雷莹, 张云芳, 钟碧贤, 等. 不同透析龄的血液透析患者死亡相关危险因素分析[J]. 中华肾脏病杂志, 2019, 35(2):147-149.
|
[17] |
CANBAY A, CELEBI O O, CELEBI S, et al. Procalcitonin:a marker of heart failure[J]. Acta Cardiol, 2015, 70(4):473-478.
DOI
URL
|
[18] |
李培培. 除外感染的充血性心力衰竭患者血清降钙素原水平的意义及主要影响因素[D]. 长春:吉林大学, 2019.
|
[19] |
ZSOM L, FALUDI M, FÜLÖP T, et al. The association of overhydration with chronic inflammation in chronic maintenance hemodiafiltration patients[J]. Hemodial Int, 2019, 23(3):384-391.
DOI
URL
|
[20] |
PEARSON T A, MENSAH G A, ALEXANDER R W, et al. Markers of inflammation and cardiovascular disease:application to clinical and public health practice:a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. Circulation, 2003, 107(3):499-511.
DOI
URL
|
[21] |
CONTI G, AMORE A, CHIESA M, et al. Procalcitonin as a marker of micro-inflammation in hemodialysis[J]. J Nephrol, 2005, 18(3):282-288.
|
[22] |
SONG K K, ZHAO D L, WANG Y D, et al. Analysis of factors associated with death in maintenance hemodialysis patients:a multicenter study in China[J]. Chin Med J(Engl), 2017, 130(8):885-891.
|
[23] |
OLIVEIRA E A, CHEUNG W W, TOMA K G, et al. Muscle wasting in chronic kidney disease[J]. Pediatr Nephrol, 2018, 33(5):789-798.
DOI
URL
|
[24] |
JIA T, GAMA AXELSSON T, HEIMBÜRGER O, et al. IGF-1 and survival in ESRD[J]. Clin J Am Soc Nephrol, 2014, 9(1):120-127.
DOI
URL
|
[25] |
尹忠诚, 吕梅月, 濮红梅. 血液透析患者外周血单核细胞COX-2的表达及其与炎症细胞因子水平的关系[J]. 中国血液净化, 2009, 8(12):649-651.
|
[26] |
XIANG F, CHEN R, CAO X, et al. Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients:a prospective cohort study[J]. Hemodial Int, 2018, 22(1):82-92.
DOI
URL
|
[27] |
HARRISON T G, SHUKALEK C B, HEMMELGARN B R, et al. Association of NT-proBNP and BNP with future clinical outcomes in patients with ESKD:a systematic review and meta-analysis[J]. Am J Kidney Dis, 2020, 76(2):233-247.
DOI
URL
|
[28] |
JACOBS L H, MINGELS A M, WODZIG W K, et al. Renal dysfunction,hemodialysis,and the NT-proBNP/BNP ratio[J]. Am J Clin Pathol, 2010, 134(3):516-517.
DOI
URL
|
[29] |
吕玉凤, 刘必成. 透析患者心血管疾病危险因素的逆流行病学现象[J]. 中华肾脏病杂志, 2006, 22(3):183-186.
|